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ABSTRACT  
The Diversity Study is a two-pronged study which evaluates both clinical research professionals 
and patient populations eligible to participate in studies.  The focus of this paper is on patient 
populations.  Specific aims regarding the patient population of this study seek to identify how 
widespread participation in clinical studies is within the Lehigh Valley Health Network (LVHN) 
community.  Additionally, opinions regarding promotional tools which may more effectively 
entice women to participate in clinical research were evaluated in a 0-4 Likert scale.  An 
overarching goal to improve diversity in research aligns with LVHN triple aim (better health, 
cost, and care) and touches on community involvement aspect of health.  Outcomes indicate that 
women in Obstetrics clinics of all races and cultures are open to participation in clinical studies 
given the right approach and resources. 
 
BACKGROUND 
It was hypothesized that the interest in and significance of promotional tools (for example, video 
explanations, medical interpretation, and support groups) is high among women, providing the 
potential to lessen the disparity within clinical research.  Education and socioeconomic status are 
thought to influence openness to participation.  In addition, it was hypothesized that the majority 
of subjects who speak a language other than English at home will not have participated in 
clinical studies.  What prevents these women from participating? 
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Disparity on the participant level was initiated in part by the Food and Drug Administration 
(FDA) more than 30 years ago when pregnant women were classified as unable to participate in 
Phase I drug trials.  Generalization of this exclusion led to a noticeable absence of women 
participants in all phases of clinical studies.
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In fact, a report reviewing 19 randomized and 
controlled cardiovascular clinical trials in 2009 revealed a low participation of 27%  by females.
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Previous clinical trial recruitment at the same location in which this study was conducted 
reported a 40% decline rate.
3
  Through The Diversity Study it is hoped that factors influencing 
women’s participation in clinical trials, or lack thereof, will be better understood.  Furthermore, 
the deeper disparity including minority women is hoped to be better understood through this 
project.  Presently, the demographics of the United States of America do not match accordingly 
to clinical research, even though studies have demonstrated that minorities are in fact not less 
willing overall to participate in clinical studies than are white subjects.
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  Literature suggests that 
mistrust of physicians and lack of participation is rooted in an overrepresentation of minorities in 
Phase I clinical trials and an underrepresentation of minorities in Phase III trials.
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Unfortunately, this dearth of women participants results in skewed conclusions from clinical 
trials due to physiological variability between men and women.
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 It is crucial to unravel the 








The Diversity Study is a two-pronged study which evaluates disparity both on the level of 
research professionals and the participant pool.  This paper refers only to the administration of 
surveys to patients in LVHN centers for women’s medicine.  Surveys were professionally 
translated into Spanish so that both English and Spanish copies were available.  An eight-page 
consent combined with a survey was administered to 400 LVHN patients age 18 years and older 
over the course of five weeks.  Research Scholars distributing surveys were able to describe the 
survey, consent participants, and answer questions regarding the survey to participants in both 
Spanish and English.  Patients were informed of the voluntary nature of the survey and given an 
opportunity to ask questions.  The survey was piloted and reviewed by 15 non-research and non-
clinical staff of LVHN prior to its distribution in clinics.  A screening log was kept of all 
individuals approached regarding the survey, and all changes and developments of this study 
have been approved by LVHN’s Institutional Review Board.  Data entry was performed by the 
Research Coordinator, Lauren Semler, and data analysis was completed by the author using 
Microsoft Excel.
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Participant Information Average 
Response 
Age 25-34 
Percent with Children 76.80% 
Previously Participated in Research Study 8.35% 
Rating of Tools For Understanding 
Research Studies 
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Table 1:  a sample of descriptive statistics of the 400 women who completed surveys.   















Occupation of Subjects Who Had 












Figure 2 displays the percentage of participants 
who participated in clinical studies previously, 







Race of Subjects Who Had 








Figure 1 displays the percentage of respondents 




















Figure 6 displays average rating of language tools for 
















Figure 5 displays the average ratings of openness to 
language tools for all survey subjects, stratified by 
educational background.   












Ratings of Interest In Supplemental 
Materials by Income, Given that 




Figure 4 displays ratings of interest in support of subjects 
who had previously participated in clinical research, 
stratified by income. 










Educational Level and Average Ranking of 
Promotional or Support Tools Given the 









Figure 3 displays ratings of interest in support of subjects 
who had previously participated in clinical research, 
















Figure 9 displays average ratings of helpfulness of 

















Figure 10 displays average ratings of helpfulness of 













Figure 8 displays average rating of support tools for 
















Figure 7 displays average rating of support tools 




DISCUSSION AND CONCLUSION 
The average age range of the women surveyed was 25-34 (p=0.0029), 76.75% of patients had 
children, and the education level of this population is “some college or 2 year degree” 
(p=0.01421).  Of the 395 participants who responded to the question asking about heritage, 
42.27% were of Hispanic descent (Table 1).  However, given that the subject had participated in 
a clinical trial previously, 84.85% of subjects spoke a language other than English at home.  This 
is indicative of a population which participates in clinical studies and has not been barred from 
participation in trials due to cultural or language differences. 
The average language spoken at home was Spanish (p=0.014264), and subjects responded on 
average that they speak and understand English “very well” (p=0.016).  The majority of subjects 
self-reported good health (median response, “Very Good,” p<0.05) and that overall health 
decisions are on average made by themselves “all” or “most of the time” (median response, “All 
of the time,” p<0.05).  This may suggest that language, illness, or lack of autonomy in decision 
making does not minimize the average subject’s openness to participation in surveys. 
While one of the locations in which the study was conducted boasts bilingual physicians and 
staff in addition to heavy involvement in research, only 8.35% of survey subjects indicated 
participation in a research study previously.  Of the participants who had previously been part of 
clinical studies, only one woman had participated in more than one study in the past five years.  
Average ratings by women who had previously participated in clinical studies of support tools 
were overall lower compared to the whole population of women who took the survey (Figures 3 
and 4).  There was high variation in veteran participant responses (not statistically significant to 
a 95% confidence interval), indicating that decision-making regarding study participation may be 
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more autonomous given prior exposure to clinical studies.  One additional piece of information 
which may add to this project is how many times the survey population had been asked to 
participate in a study over the past year. 
In rating tools by helpfulness in terms of deciding whether or not to participate in clinical 
studies, more personal options such as support groups and opportunities to speak with prior 
participants were rated slightly higher than written explanations or video support by the whole 
survey population.  The median for each tool was rated at 3 on a 0-4 Likert scale, with 4 being 
the most helpful.  The highest rating median of 4 was given to “Having material provided in my 
own language,” however; the average rating was 3.21 (similar to other option responses) with a 
p-value of 0.0547, which is not statistically significant (Figures 5-10). 
Given that the subject had previously participated in clinical studies, 17% of those subjects were 
employed in health care or science fields.  The women who had previously participated in 
clinical studies identified as 20% Hispanic, 50% white/Caucasian, and 20% black or African 
American and the average education was “some high school” (Figures 1 and 2).  It could be said 
that the group which previously participated was somewhat diverse in educational, ethnic, and 
socioeconomic background.  The trend based on education follows that the subjects with the 
most and least education rated less importance on supportive tools to improve openness to 
clinical studies than those in the middle of the educational spectrum (high school or some 
college).  The average respondent was of an income $30,000 or less, which is reflective of the 
area in which the study was conducted.  The highest importance of promotional tools was rated 
by the lowest income subjects who had previously participated in clinical studies (Figures 3, 4).   
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Limitations to this study include several confounders and logistical challenges.  The survey was 
available in English for more days during the study than Spanish.  Confounding factors of 
incompleteness due to a lack of comfort with the question type or the subject’s English fluency 
could have influenced responses.  A final confounder could lie in the responses in English 
surveys versus Spanish surveys given the subject’s English fluency. 
Outcomes of this study suggest that women are in fact open to educational and supportive 
resources which may increase openness to participation in clinical studies.  It can be said that the 
hypothesis regarding interest and openness to promotional tools and clinical studies is high 
among women was correct.  Education and socioeconomic status relatively influenced openness 
to participation.  Between video and written explanation ratings, written was rated higher overall.  
Between the option to speak with a prior participant of the study and to have a support group, the 
option to speak with a prior participant was rated higher.  Between the option for materials in the 
subject’s own language and access to a medical interpreter, materials in the subject’s own 
language were the highest and clearest preference.  These three preferred tools would make for a 
good base in further testing.   
The final hypothesis that the majority of subjects who speak a language other than English at 
home would not have participated in clinical studies was not accepted.  Results indicate that over 
80% of the participants of clinical studies did in fact speak a language other than English at 
home.  The largest factor which may improve openness to clinical studies may lie in the 
approach and provision of support to participants. 
Further research directions include identifying a consensus of openness to materials of reference 
and in-person support which is positive and able to be implemented.  Utilization of discrete 
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materials at various enrollment sites and comparison between outcomes given the support tool as 
a sole variable could help better identify which tool is best for the women and minority 
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